{"transactions":[{"id":675178,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":19556,"kind":"person","name":"Potashnick Robert","position":1,"cik":"0001939454","reported_name":"Potashnick Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO & VP of Finance"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-26T21:08:23.000Z","date":"2026-08-24","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to purchase 62,500 shares vest on 8/24/2027, and 187,500 shares vest pro rata on the 24th of each month thereafter for 36 consecutive months."}],"balance_after":250000,"derivative":{"exercise_price":0.746,"expiration_date":"2036-08-24","underlying":"Class A Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000914190-26-000137","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1939454/000091419026000137/form4.xml","form_type":"4"}},{"id":901327,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":19556,"kind":"person","name":"Potashnick Robert","position":1,"cik":"0001939454","reported_name":"Potashnick Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Warrant (right to buy)","published_at":"2026-02-17T21:49:33.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":212500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable upon shareholder approval of the issuance of shares of Class A Common Stock underlying the warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series A-2 Warrants expire on the earlier of (i) five years from the initial exercise date and (ii) 30 days after the date on which the Company announces that it has received FDA approval for its Acclaim CI Device."}],"balance_after":212500,"derivative":{"exercise_price":0.4,"underlying":"Class A Common Stock","underlying_shares":212500},"source":{"system":"sec-edgar","filing":"0000914190-26-000027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1939454/000091419026000027/form4.xml","form_type":"4"}},{"id":901326,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":19556,"kind":"person","name":"Potashnick Robert","position":1,"cik":"0001939454","reported_name":"Potashnick Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Warrant (right to buy)","published_at":"2026-02-17T21:49:33.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":127500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable upon shareholder approval of the issuance of shares of Class A Common Stock underlying the warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series A-1 Warrants expire on the earlier of (i) two years from the initial exercise date and (ii) 30 days after the date on which the Company announces that it has submitted a Premarket Approval Application to the Food and Drug Administration (FDA) for its Acclaim CI Device."}],"balance_after":127500,"derivative":{"exercise_price":0.4,"underlying":"Class A Common Stock","underlying_shares":127500},"source":{"system":"sec-edgar","filing":"0000914190-26-000027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1939454/000091419026000027/form4.xml","form_type":"4"}},{"id":901325,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":19556,"kind":"person","name":"Potashnick Robert","position":1,"cik":"0001939454","reported_name":"Potashnick Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Class A Common Stock","published_at":"2026-02-17T21:49:33.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":212500,"price":0.4,"value":85000.0,"ownership":{"direct":true},"balance_after":212500,"source":{"system":"sec-edgar","filing":"0000914190-26-000027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939454/000091419026000027/form4.xml","form_type":"4"}},{"id":914623,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":19556,"kind":"person","name":"Potashnick Robert","position":1,"cik":"0001939454","reported_name":"Potashnick Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-09T22:45:38.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 3,750 shares vest on 2/5/2027, and 11,250 shares vest pro rata on the 5th of each month thereafter for 36 consecutive months."}],"balance_after":15000,"derivative":{"exercise_price":0.53,"expiration_date":"2036-02-05","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000914190-26-000015","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939454/000091419026000015/form4.xml","form_type":"4"}},{"id":2157607,"issuer":{"id":8683,"kind":"organization","name":"FOXO TECHNOLOGIES INC."},"owners":[{"id":19556,"kind":"person","name":"Potashnick Robert","position":1,"cik":"0001939454","reported_name":"Potashnick Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-09-17T01:41:28.000Z","date":"2022-09-15","kind":"grant","acquired":true,"shares":2,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock options were received in exchange for stock options to purchase 5 shares of Class A common stock of FOXO in connection with the Merger. As of the Closing Date, 0.39 of the shares of Class A common stock of the Issuer subject to the stock options were vested, and, thereafter, the remaining number of shares subject to the stock options shall vest in equal monthly installments until fully vested on 1/27/2025."}],"balance_after":2,"derivative":{"exercise_price":15.76,"expiration_date":"2027-01-27","underlying":"Class A Common Stock","underlying_shares":2},"source":{"system":"sec-edgar","filing":"0001213900-22-056729","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1939454/000121390022056729/ownership.xml","form_type":"4"}},{"id":2157606,"issuer":{"id":8683,"kind":"organization","name":"FOXO TECHNOLOGIES INC."},"owners":[{"id":19556,"kind":"person","name":"Potashnick Robert","position":1,"cik":"0001939454","reported_name":"Potashnick Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-09-17T01:41:28.000Z","date":"2022-09-15","kind":"grant","acquired":true,"shares":3571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options were received in exchange for stock options to purchase 6,148 shares of Class A common stock of FOXO in connection with the Merger. As of the Closing Date, 1,289.54 of the shares of Class A common stock of the Issuer subject to the stock options were vested, and, thereafter, the remaining number of shares subject to the stock options shall vest in equal monthly installments until fully vested on 8/9/2024."}],"balance_after":3571,"derivative":{"exercise_price":6.51,"expiration_date":"2026-08-09","underlying":"Class A Common Stock","underlying_shares":3571},"source":{"system":"sec-edgar","filing":"0001213900-22-056729","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1939454/000121390022056729/ownership.xml","form_type":"4"}},{"id":2157605,"issuer":{"id":8683,"kind":"organization","name":"FOXO TECHNOLOGIES INC."},"owners":[{"id":19556,"kind":"person","name":"Potashnick Robert","position":1,"cik":"0001939454","reported_name":"Potashnick Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-09-17T01:41:28.000Z","date":"2022-09-15","kind":"grant","acquired":true,"shares":78413,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were received in exchange for stock options to purchase 135,000 shares of Class A common stock of FOXO Technologies Operating Company (\"FOXO\") in connection with the merger of FOXO with and into a wholly owned subsidiary of the Issuer (the \"Merger\"), which closed on 9/15/2022 (the \"Closing Date\"). As of the Closing Date, 43,562.78 of the shares of Class A common stock of the Issuer subject to the stock options were vested, and, thereafter, the remaining number of shares subject to the stock options shall vest in equal monthly installments until fully vested on 12/31/2023."}],"balance_after":78413,"derivative":{"exercise_price":6.51,"expiration_date":"2026-04-02","underlying":"Class A Common Stock","underlying_shares":78413},"source":{"system":"sec-edgar","filing":"0001213900-22-056729","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1939454/000121390022056729/ownership.xml","form_type":"4"}},{"id":2157604,"issuer":{"id":8683,"kind":"organization","name":"FOXO TECHNOLOGIES INC."},"owners":[{"id":19556,"kind":"person","name":"Potashnick Robert","position":1,"cik":"0001939454","reported_name":"Potashnick Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-17T01:41:28.000Z","date":"2022-09-15","kind":"grant","acquired":true,"shares":510000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"In connection with the Merger (as defined below), the reporting person received a restricted share award equal to 510,000 shares of Class A common stock of the Issuer pursuant to the terms and conditions of the FOXO Technologies Inc. Management Contingent Share Plan (the \"MIP\"). The restricted share award is subject to the following three service-based vesting conditions (i) 60% of the award will become vested on the 3rd anniversary of the Closing Date (as defined below) if the reporting person is still employed by the Issuer on such date, (ii) ) 20% of the award will become vested on the 4th anniversary of the Closing Date if the reporting person is still employed by the Issuer on such date, and (iii) the final 20% of the award will become vested on the 5th anniversary of the Closing Date if the reporting person is still employed by the Issuer on such date. In addition, 1/3 of the restricted share award will become vested upon the satisfaction of certain performance-based conditions as further described in the MIP."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the Merger (as defined below), the reporting person received a restricted share award equal to 510,000 shares of Class A common stock of the Issuer pursuant to the terms and conditions of the FOXO Technologies Inc. Management Contingent Share Plan (the \"MIP\"). The restricted share award is subject to the following three service-based vesting conditions (i) 60% of the award will become vested on the 3rd anniversary of the Closing Date (as defined below) if the reporting person is still employed by the Issuer on such date, (ii) ) 20% of the award will become vested on the 4th anniversary of the Closing Date if the reporting person is still employed by the Issuer on such date, and (iii) the final 20% of the award will become vested on the 5th anniversary of the Closing Date if the reporting person is still employed by the Issuer on such date. In addition, 1/3 of the restricted share award will become vested upon the satisfaction of certain performance-based conditions as further described in the MIP."}],"balance_after":510000,"source":{"system":"sec-edgar","filing":"0001213900-22-056729","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939454/000121390022056729/ownership.xml","form_type":"4"}}]}